Preview

Инфекция и иммунитет

Расширенный поиск

Пандемия COVID-19: систематический обзор современных данных

https://doi.org/10.15789/2220-7619-TCP-1508

Полный текст:

Аннотация

Введение. Эпидемия коронавирусного заболевания 2019 г. (COVID-19) началась в декабре 2019 г. в Китае и представляет серьезную проблему. Одним из важных вопросов является ее быстрое распространение во всем мире. В ряде работ были описаны эпидемиология, клинико-лабораторные признаки, рентгенологические характеристики и лечение COVID-19. Однако в настоящее время в доступной литературе отсутствуют систематические обзоры, описывающие накопленные данные по COVID-19.

Цель: описание эпидемиологии COVID-19, а также клинических особенностей, диагностики и лечения.

Материалы и методы. Проведен систематический обзор литературы по ключевым словам «коронавирус» и «2020», «COV-ID-19» в базах данных: Science Direct, PubMed, Springer и Scopus за период с 1 января 2020 г. по 23 февраля 2020 г.

Отбор типа исследований: все обсервационные исследования, а также описание клинических случаев и редакционных комментариев на английском языке. Извлечение данных: различными наблюдателямипроизводилось извлечение данных по методам контроля COVID-19.

Результаты. В результате поиска удалось обнаружить 131 статью. После оценки содержания тезисов и названия статей были отобраны 58 работ для анализа полного текста статей, из которых в обзор включены 43 статьи. COVID-19 быстро распространяется и передается при тесном контакте между людьми через назо- и орофарингеальные аэрозоли. COVID-19 вызывал существенные проблемы, особенно у пациентов с сопутствующими заболеваниями и у лиц пожилого возраста. Основными клиническими чертами COVID-19 были лихорадка, кашель, боли в горле и диарея. Наиболее распространенным рентгенологическим признаком заболевания был картина двустороннего матового стекла. Для этиотропной терапии применялись Лопинавир и Ритонавир.

Выводы. COVID-19 является новым инфекционным заболеванием и представляет серьезную проблему для здравоохранения. Требуется проведение дополнительных исследований для определения факторов, которые могут опосредовать развитие патогенеза тяжелой и фатальной формы заболевания.

Ключевые слова


Об авторах

Р. Гоми
Исфаханский Университет медицинских наук
Иран


Н. Асгари
Исфаханский университет медицинских наук
Иран


А. Хаджихейдари
Исфаханский университет медицинских наук
Иран


Р. Эстеки
Исфаханский университет медицинских наук
Иран


Ф. Бйабанаки
Исфаханский университет медицинских наук
Иран


Ф. Насиринасаб
Исфаханский университет медицинских наук
Иран


Список литературы

1. Al-Tawfiq J.A., Zumla A., Memish Z.A. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med. Infect. Dis., 2014, vol. 12, no. 5, pp. 422—428. doi: 10.1016/j.tmaid.2014.06.007

2. Albarello F., Pianura E., Di Stefano F., Cristofaro M., Petrone A., Marchioni L., Palazzolo C., Schinina V., Nicastri E., Petrosillo N., Campioni P., Eskild P., Zumla A., Ippolito G.; COVID 19 INMI Study Group. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation. Int. J. Infect. Dis., 2020, vol. 93, pp. 192-197. doi: 10.1016/j.ijid.2020.02.043

3. Arabi Y.M., Alothman A., Balkhy H.H., Al-Dawood A., Al Johani S., Al Harbi S., Kojan S., Al Jeraisy M., Deeb A.M., Assiri A.M., Al-Hameed F., Al Saedi A., Mandourah Y., Almekhlafi G.A., Sherbeeni N.M., Elzein F.E., Memon J., Taha Y., Almotairi A., Maghrabi K.A., Qushmaq I., Al Bshabshe A., Kharaba A., Shalhoub S., Jose J., Fowler R.A., Hayden F.G., Hussein M.A.; The MIRACLE trial group. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-в 1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials, 2018, vol. 19, no. 1: 81. doi: 10.1186/s13063-017-2427- 0

4. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A., Flemban H., Al-Nassir W.N., Balkhy H.H., Al-Hakeem R.F., Makhdoom H.Q., Zumla A.I., Memish Z.A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis,, 2013, vol. 13, no. 9, pp. 752-61. doi: 10.1016/S1473-3099(13)70204-4

5. Bai Y., Yao L., Wei T., Tian F., Jin D.Y., Chen L., Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA, 2020, vol. 323, no. 14, pp. 1406-1407. doi: 10.1001/jama.2020.2565

6. Bonilla-Aldana D.K., Quintero-Rada K., Montoya-Posada J.P., Ramfrez-Ocampo S., Paniz-Mondolfi A., Rabaan A.A., Sah R., Rodrfguez-Morales A.J. SARS-CoV, MERS-CoV and now the 2019-novel CoV: have we investigated enough about coronavi-ruses? A bibliometric analysis. Travel Med. Infect. Dis., 2020, vol. 33:101566. doi: 10.1016/j.tmaid.2020.101566

7. Centers for Disease Control and Prevention C. 2019 Novel Coronavirus (2019-nCoV). 2020. URL: https://www.cdc.gov/coronavirus/2019-ncov/index.html

8. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W., Tsoi H.W., Lo S.K., Chan K.H., Poon V.K., Chan W.M., Ip J.D., Cai J.P., Cheng V.C., Chen H., Hui C.K., Yuen K.Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, vol. 395, no. 10223, pp. 514-523. doi: 10.1016/S0140-6736(20)30154-9

9. Chan-Yeung M., Xu R.H. SARS: epidemiology. Respirology, 2003, vol. 8 (suppl. 1), pp. S9-S14. doi: 10.1046/j.1440-1843.2003.00518.x. PMID: 15018127; PMCID: PMC7169193.

10. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q., Liao J., Yang H., Hou W., Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet, 2020, vol. 395, pp. 809-815. doi: 10.1016/j.jemermed.2020.04.003

11. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, vol. 395, no. 10223, pp. 507-513. doi: 10.1016/S0140-6736(20)30211-7

12. Chen Q., Liang M., Li Y., Guo J., Fei D., Wang L., He L., Sheng C., Cai Y., Li X., Wang J., Zhang Z. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, vol. 7, no. 4, pp. e15-e16. doi: 10.1016/S2215-0366(20)30078-X

13. Chen X., Tian J., Li G., Li G. Initiation of a new infection control system for the COVID-19 outbreak. Lancet Infect Dis., 2020, vol. 20, no. 4, pp. 397-398. doi: 10.1016/S1473-3099(20)30110-9

14. Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol., 2020, vol. 92, no. 4, pp. 418-423. doi: 10.1002/jmv.25681

15. Cheng Z.J., Shan J. 2019 Novel coronavirus: where we are and what we know. Infection., 2020, vol. 48, no. 2, pp. 155-163. doi: 10.1007/s15010-020-01401-y

16. Chu C.M., Cheng V.C., Hung I.F., Wong M.M., Chan K.H., Chan K.S., Kao R.Y., Poon L.L., Wong C.L., Guan Y., Peiris J.S., Yuen K.Y.; HKU/UCH SARS Study Group. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax, 2004, vol. 59, no. 3, pp. 252-256. doi: 10.1136/thorax.2003.012658

17. Cohen E.C. CDC to screen at three US airports for signs of new virus from China. CNN Health. 2020. January 17. URL: https://edition.cnn.com/2020/01/17/health/wuhan-virus-us-airport-screenings-china-bn/index.html

18. COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 2 (Reporting week ending 19:00 AEDT 8 February 2020). Commun. Dis. Intell. (2018), 2020: 44. doi: 10.33321/cdi.2020.44.14

19. COVID-19: fighting panic with information. Lancet, 2020, vol. 395, no. 10224, p. 537. doi: 10.1016/S0140-6736(20)30379-2

20. De Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., Fouchier R.A., Galiano M., Gorbalenya A.E., Memish Z.A., Perlman S., Poon L.L., Snijder E.J., Stephens G.M., Woo P.C., Zaki A.M., Zambon M., Ziebuhr J. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol., 2013, vol. 87, no. 14, pp. 7790-7792. doi: 10.1128/JVI.01244-13

21. De Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol., 2016, vol. 14, no. 8, pp. 523-534. doi: 10.1038/nrmicro.2016.81

22. Gao J., Tian Z., Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends, 2020, vol. 14, no. 1, pp. 72-73. doi: 10.5582/bst.2020.01047

23. Gardner L. Mapping COVID-19. 2020. URL: https://systems.jhu.edu/research/public-health/ncov

24. Gostic K., Gomez A.C., Mummah R.O., Kucharski A.J., Lloyd-Smith J.O. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife, 2020, vol. 9: e55570. doi: 10.7554/eLife.55570

25. Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D.S.C., Du B., Li L., Zeng G., Yuen K.-Y., Chen R., Tang C., Wang T., Chen P., Xiang J., Li S., Wang J., Liang Z., Peng Y., Wei L., Liu Y., Hu Y., Peng P., Wang J., Liu J., Chen Z., Li G., Zheng Z., Qiu S., Luo J., Ye C., Zhu S., Zhong N., for the China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 2020, vol. 382, pp. 1708-1720. doi: 10.1056/NEJMoa2002032

26. Guarner J. Three emerging coronaviruses in two decades. Am. J. Clin. Pathol., 2020, vol. 153, no. 4, pp. 420-421. doi: 10.1093/ajcp/aqaa029

27. Habibzadeh P., Stoneman E.K. The Novel Coronavirus: a bird’s eye view. Int. J. Occup. Environ. Med., 2020, vol. 11, no. 2, pp. 6571. doi: 10.15171/ijoem.2020.1921

28. Hernandez J.C., Austin Ramzy T. China confirms new coronavirus spreads from humans to humans. The New York Times. 2020. 24 January. URL: https://www.nytimes.com/2020/01/20/world/asia/coronavirus-china-symptoms.html

29. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, vol. 395, no. 10223, pp. 497-506. doi: 10.1016/S0140-6736(20)30183-5

30. Jalava K. First respiratory transmitted food borne outbreak? Int. J. Hyg. Environ. Health, 2020, vol. 226: 113490. doi: 10.1016/j.ijheh.2020.113490

31. Kim H. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? Eur. Radiol., 2020, vol. 30, pp. 3266-3267. doi: 10.1007/s00330-020-06748-2

32. Kim J.Y., Ko J.H., Kim Y., Kim Y.J., Kim J.M., Chung Y.S., Kim H.M., Han M.G., Kim S.Y., Chin B.S. Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J. Korean Med. Sci., 2020, vol. 35, no. 7: e86. doi: 10.3346/jkms.2020.35.e86

33. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coro-navirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents, 2020, vol. 55, no. 3: 105924. doi: 10.1016/j.ijantimicag.2020.105924

34. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., Ahuja A., Yung M.Y., Leung C.B., To K.F., Lui S.F., Szeto C.C., Chung S., Sung J.J. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med., 2003, vol. 348, no. 20, pp. 1986-1994. doi: 10.1056/NEJMoa030685

35. Liem A., Wang C., Wariyanti Y., Latkin C.A., Hall B.J. The neglected health of international migrant workers in the COVID-19 epidemic. Lancet Psychiatry, 2020, vol. 7, no. 4: e20. doi: 10.1016/S2215-0366(20)30076-6

36. Lim J., Jeon S., Shin H.Y., Kim M.J., Seong Y.M., Lee W.J., Choe K.W., Kang Y.M., Lee B., Park S.J. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of Lopinavir/Ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J. Korean. Med. Sci., 2020, vol. 35, no. 6: e79. doi: 10.3346/jkms.2020.35.e79

37. Lin C., Ding Y., Xie B., Sun Z., Li X., Chen Z., Niu M. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease. Clin. Imaging, 2020, vol. 63, pp. 7-9. doi: 10.1016/j.clinimag.2020.02.008

38. Lin X., Gong Z., Xiao Z., Xiong J., Fan B., Liu J. Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases. Korean J. Radiol., 2020, vol. 21, no. 3, pp. 365-368. doi: 10.3348/kjr.2020.0078

39. Liu S., Yang L., Zhang C., Xiang Y.T., Liu Z., Hu S., Zhang B. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, vol. 7, no. 4, pp. e17-e18. doi: 10.1016/S2215-0366(20)30077-8

40. Lum L.H.W., Tambyah P.A. Outbreak of COVID-19 — an urgent need for good science to silence our fears? Singapore Med. J., 2020, vol. 61, no. 2, pp. 55-57. doi: 10.11622/smedj.2020018

41. MacLaren G., Fisher D., Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA, 2020, vol. 323, no. 13, pp. 1245-1246. doi: 10.1001/jama.2020.2342

42. Moher D., Liberati A., Tetzlaff J., Altman D.G.; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med., 2009, vol. 6, no. 7: e1000097. doi: 10.1371/journal.pmed.1000097

43. Nassar M.S., Bakhrebah M.A., Meo S.A., Alsuabeyl M.S., Zaher W.A. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. Eur. Rev. Med. Pharmacol, Sci., 2018, vol. 22, no. 15, pp. 4956-4961. doi: 10.26355/eurrev_201808_15635

44. Pan Y., Guan H. Imaging changes in patients with 2019-nCov. Eur. Radiol., 2020, vol. 30, no. 7, pp. 3612-3613. doi: 10.1007/s00330-020-06713-z

45. Peeri N.C., Shrestha N., Rahman M.S., Zaki R., Tan Z., Bibi S., Baghbanzadeh M., Aghamohammadi N., Zhang W., Haque U. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int. J. Epidemiol., 2020, vol. 49, no. 3, pp. 717-726. doi: 10.1093/ije/dyaa033

46. Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet, 2020, vol. 395, no. 10226,pp. 760-762. doi: 10.1016/S0140-6736(20)30365-2

47. Qin C., Liu F., Yen T.C., Lan X. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur. J. Nucl. Med. Mol. Imaging, 2020, vol. 47, no. 5, pp. 1281-1286. doi: 10.1007/s00259-020-04734-w

48. Rivers C.M., Majumder M.S., Lofgren E.T. Risks of death and severe disease in patients with Middle East Respiratory Syndrome Coronavirus, 2012—2015. Am. J. Epidemiol, 2016, vol. 184, no. 6, pp. 460-464. doi: 10.1093/aje/kww013

49. Sabino-Silva R., Jardim A.C.G., Siqueira W.L. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin. OralInvestig., 2020, vol. 24, no. 4, pp. 1619-1621. doi: 10.1007/s00784-020-03248-x

50. Sheahan T.P., Sims A.C., Graham R.L., Menachery V.D., Gralinski L.E., Case J.B., Leist S.R., Pyrc K., Feng J.Y., Trantcheva I., Bannister R., Park Y., Babusis D., Clarke M.O., Mackman R.L., Spahn J.E., Palmiotti C.A., Siegel D., Ray A.S., Cihlar T., Jordan R., Denison M.R., Baric R.S. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl. Med., 2017, vol. 9, no. 396: eaal3653. doi: 10.1126/scitranslmed.aal3653

51. Sheahan T.P., Sims A.C., Leist S.R., Schafer A., Won J., Brown A.J., Montgomery S.A., Hogg A., Babusis D., Clarke M.O., Spahn J.E., Bauer L., Sellers S., Porter D., Feng J.Y., Cihlar T., Jordan R., Denison M.R., Baric R.S. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun., 2020, vol. 11, no. 1,p. 222. doi: 10.1038/s41467-019-13940-6

52. Song P., Karako T. COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern. Biosci. Trends, 2020, vol. 14, no. 1, pp. 1-2. doi: 10.5582/bst.2020.01056

53. Srikantiah P., Charles M.D., Reagan S., Clark T.A., Pletz M.W., Patel P.R., Hoekstra R.M., Lingappa J., Jernigan J.A., Fischer M. SARS clinical features, United States, 2003. Emerg. Infect. Dis., 2005, vol. 11, no. 1, pp. 135-138. doi: 10.3201/eid1101.040585

54. Tian S., Hu N., Lou J., Chen K., Kang X., Xiang Z., Chen H., Wang D., Liu N., Liu D., Chen G., Zhang Y., Li D., Li J., Lian H., Niu S., Zhang L., Zhang J. Characteristics of COVID-19 infection in Beijing. J. Infect., 2020, vol. 80, no. 4, pp. 401-406. doi: 10.1016/j.jinf2020.02.018

55. Tong Z.D., Tang A., Li K.F., Li P., Wang H.L., Yi J.P., Zhang Y.L., Yan J.B. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020. Emerg. Infect. Dis, 2020, vol. 26, no. 5, pp. 1052-1054. doi: 10.3201/eid2605.200198

56. Tsang K.W., Ho P.L., Ooi G.C., Yee W.K., Wang T., Chan-Yeung M., Lam W.K., Seto W.H., Yam L.Y., Cheung T.M., Wong P.C., Lam B., Ip M.S., Chan J., Yuen K.Y., Lai K.N. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med, 2003, vol. 348, no. 20, pp. 1977-85. doi: 10.1056/NEJMoa030666

57. Van Cuong L., Giang H.T.N., Linh L.K., Shah J., Van Sy L., Hung T.H., Reda A., Truong L.N., Tien D.X., Huy N.T. The first Vietnamese case of COVID-19 acquired from China. Lancet Infect. Dis., 2020, vol. 20, no. 4, pp. 408-409. doi: 10.1016/S1473-3099(20)30111-0

58. Velavan T.P., Meyer C.G. The C.O.V.ID-19 epidemic. Trop. Med. Int. Health, 2020, vol. 25, no. 3, pp. 278-280. doi: 10.1111/tmi.13383

59. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet, 2020, vol. 395, no. 10223, pp. 470-473. doi: 10.1016/S0140-6736(20)30185-9

60. Wong J.E.L., Leo Y.S., Tan C.C. COVID-19 in Singapore-current experience: critical global issues that require attention and action. JAMA,, 2020, vol. 323, no. 13, pp. 1243-1244. doi: 10.1001/jama.2020.2467

61. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report-66. 2020. URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=9e5b8b48_2

62. Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X., Zheng M., Chen L., Li H. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B., 2020, vol. 10, no. 5, pp. 766-788. doi: 10.1016/j.apsb.2020.02.008

63. Wu J., Wu X., Zeng W., Guo D., Fang Z., Chen L., Huang H., Li C. Chest CT findings in patients with Coronavirus Disease 2019 and its relationship with clinical features. Invest. Radiol., 2020, vol. 55, no. 5, pp. 257-261. doi: 10.1097/RLI.0000000000000670

64. Wu J.T., Leung K., Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet, 2020, vol. 395, no. 10225, pp. 689-697. doi: 10.1016/S0140-6736(20)30260-9

65. Xu Y.H., Dong J.H., An W.M., Lv X.Y., Yin X.P., Zhang J.Z., Dong L., Ma X., Zhang H.J., Gao B.L. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J. Infect., 2020, vol. 80, no. 4, pp. 394-400. doi: 10.1016/j.jinf2020.02.017

66. Xu Z., Li S., Tian S., Li H., Kong L.Q. Full spectrum of COVID-19 severity still being depicted. Lancet., 2020, vol. 395, no. 10228, pp. 947-948. doi: 10.1016/S0140-6736(20)30308-1

67. Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., Yu T., Wang Y., Pan S., Zou X., Yuan S., Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med., 2020, vol. 8, no. 5, pp. 475-481. doi: 10.1016/S2213-2600(20)30079-5

68. Yang Y., Li W., Zhang Q., Zhang L., Cheung T., Xiang Y.T. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, vol. 7, no. 4: e19. doi: 10.1016/S2215-0366(20)30079-1

69. Yang Y., Shang W., Rao X. Facing the COVID-19 outbreak: what should we know and what could we do? J. Med. Virol., 2020, vol. 92, no. 6, pp. 536-537. doi: 10.1002/jmv.25720

70. Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 2018, vol. 23, no. 2, pp. 130137. doi: 10.1111/resp.13196

71. Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q., Akdis C.A., Gao Y.D. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020, vol. 75, no. 7, pp. 1730-1741. doi: 10.1111/all.14238

72. Zhang S., Diao M., Yu W., Pei L., Lin Z., Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis. Int. J. Infect. Dis., 2020, vol. 93, pp. 201-204. doi: 10.1016/j.ijid.2020.02.033

73. Zhang Y., Xu J., Li H., Cao B. A novel coronavirus (COVID-19) outbreak: a call for action. Chest, 2020, vol. 157, no. 4, pp. e99-e101. doi: 10.1016/j.chest.2020.02.014

74. Zhu Y., Chen L., Ji H., Xi M., Fang Y., Li Y.. The risk and prevention of novel coronavirus pneumonia infections among inpatients in psychiatric hospitals. Neurosci. Bull., 2020, vol. 36, no. 3,pp. 299-302. doi: 10.1007/s12264-020-00476-9


Для цитирования:


Гоми Р., Асгари Н., Хаджихейдари А., Эстеки Р., Бйабанаки Ф., Насиринасаб Ф. Пандемия COVID-19: систематический обзор современных данных. Инфекция и иммунитет. 2020;10(4):655-663. https://doi.org/10.15789/2220-7619-TCP-1508

For citation:


Ghomi R., Asgari N., Hajiheydari A., Esteki R., Biyabanaki F., Nasirinasab F. The COVID-19 pandemic: a systematic review of the current evidence. Russian Journal of Infection and Immunity. 2020;10(4):655-663. https://doi.org/10.15789/2220-7619-TCP-1508

Просмотров: 202


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2220-7619 (Print)
ISSN 2313-7398 (Online)